Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- CORPORATE ROUNDUP NEWS IN BRIEF
April 23, 2001
- DIAGNOSTICS NEWS IN BRIEF
April 23, 2001
- NEW PRODUCTS NEWS IN BRIEF
April 23, 2001
- Kureha, Sankyo Tie Up for Joint Development of CXCR4 Blocker
April 23, 2001
- Patients"Success Rate Increases to Record High in 2000: Malpractice Lawsuits
April 23, 2001
- Market Share of Generics Should Be Considered in Pricing of Long-listed Drugs: JMA
April 23, 2001
- LDP's Commission Lists 4 Points of Discussion for NHI Pricing Reform
April 23, 2001
- Mr MRto Enable Physicians to Easily Access Information: Mr Tanimura of So-net M3
April 23, 2001
- REGULATORY NEWS IN BRIEF
April 23, 2001
- MEDICAL DEVICE NEWS IN BRIEF
April 23, 2001
- Marketing of Half-strength Preparations of Digoxin Expected
April 23, 2001
- Fujisawa, ORIX Capital Establishes New Investment Fund
April 23, 2001
- OBITUARY
April 23, 2001
- Eisai Subscribes to Incyte Genomics"Databases
April 23, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
April 23, 2001
- Mochida, Maruishi to Jointly Develop Capsaicin-based Cream
April 23, 2001
- Lilly's Gemzar Approved for Pancreatic Cancer Treatment
April 23, 2001
- Pharmacia's Zyvox Approved
April 23, 2001
- First Int'l GL for COPD Published
April 23, 2001
- GSK Obtains Import Approval for Alkeran for Injection 50mg
April 23, 2001
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…